Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RISPERIDONE
- Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer
- Dexmedetomidine Effect on Delirium of Elderly Patients
- Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
- Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine
- EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIAL
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia
- Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
- Does Psilocybin Require Psychedelic Effects to Treat Depression?
- A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
- Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder
- Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)
- Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
- Comparative Bioavailability of Risperidone.
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
- Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment
- Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
- Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
- Reducing the Abuse Liability of Prescription Opioids
- Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
- A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules in Subjects With Schizophrenia, Schizoaffective Disorder
- Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
- CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
- A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
- "Extended" (Alternate Day) Antipsychotic Dosing
- Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
- Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
- Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
- Risperidone for the Treatment of Huntington's Disease Involuntary Movements
- Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
- The Phosphodiesterase Inhibitor Pentoxifylline as an Adjuvant in Treatment of Negative Symptoms in Chronic Schizophrenia
- The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
- Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
- Clinical Utility of Pharmacogenomics of Psychotropic Medications
- A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia
- Therapeutic Issues for Autism
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
- Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
- Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
- A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
- A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Comparative Bioavailability of Risperidone
- Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime
- Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia
- Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
- Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
- Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
- Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
- A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
- Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia
- An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
- Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
- The Optimal Treatment for Treatment-resistant Schizophrenia
- Enhancing Recovery in Early Schizophrenia
- Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Striatal Connectivity and Clinical Outcome in Psychosis
- Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy
- Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
- MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
- Safety and Tolerability of Risperidone Implants
- Single Ascending Dose Study of RBP-7000
- First in Man Study of Safety, Tolerability and PK Profile of RBP-7000
- Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
- Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
- PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia
- Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
- Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
- Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
- Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
- A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia
- A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
- Antipsychotics and Risk of Hyperglycemic Emergencies
- Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
- Nicotinic Receptors and Schizophrenia
- Schizotypal Personality Disorder Risperidone
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
- A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
- Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
- Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia
- A Pharmacokinetic Study of Paliperidone ER
- A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
- Neuroendocrine and Metabolite Substrates in Schizophrenia
- Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
- Pharmacovigilance in Gerontopsychiatric Patients
- Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
- Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
- Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- Antipsychotic to Treat Psychosis Syndrome
- Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium
- Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
- A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women
- Association of Amisulpride Response in Schizophrenia With Brain Image
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
- Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia
- Depakote (Divalproex Sodium) for Children With Temper Dysregulation and Severe Mood Swings
- Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
- Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
- Glutamate, Brain Connectivity and Duration of Untreated Psychosis
- Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
- The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia
- A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
- Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia
- A Clinical Trial of Lurasidone in Treatment of Schizophrenia
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
- Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers
- Antipsychotic Effects on Brain Function in Schizophrenia
- Interpersonal Psychotherapy for Treatment Resistant Depression
- An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
- Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
- An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders
- Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
- 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
- A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis
- A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis
- Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths
- Omega-3 Dietary Supplements in Schizophrenia
- Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
- Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
- A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
- Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
- Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition
- Pioglitazone for the Treatment of Bipolar Depression
- Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers
- Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
- A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia
- Clozapine for Cannabis Use in Schizophrenia
- A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
- A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder
- Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics
- A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
- A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia
- Ginkgo Biloba Extract for Schizophrenia
- Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
- Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel
- Study of a Novel Antipsychotic ITI-007 in Schizophrenia
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
- POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia
- Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
- Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea
- Risperidone and Desipramine in Alcohol Use and Schizophrenia
- Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
- Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia
- Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
- Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
- Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
- Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®
- Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia
- Safety and Efficacy of Zicronapine in Patients With Schizophrenia
- Different Safety Profile of Risperidone and Paliperidone Extended-release
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
- Paliperidone Palmitate Flexible Dosing in Schizophrenia
- Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI
- Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions
- Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
- Switching to Iloperidone From Other Antipsychotics in Schizophrenia
- Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients
- Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
- A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
- Add-On Therapy to Risperidonein Schizophrenia
- Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
- Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
- An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia
- Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
- Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
- 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
- Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
- Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
- A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
- Effects of Ketamine and Risperidone on Cognition
- Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
- A Long-Term, Open-Label, Study on Schizophrenia
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
- A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate
- A Study in Schizophrenia Patients
- Is MS14 Helpful in Schizophrenia?
- Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition
- Standard Comprehensive Intervention to Treat First-episode Schizophrenia
- A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
- Trichuris Suis Ova in Autism Spectrum Disorders
- InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics
- A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone
- TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
- Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia
- An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
- A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders
- Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years
- Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed Conditions
- Bioequivalence Study of Risperidone 1.0 mg Tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fasting Conditions
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning
- A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patient
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
- Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
- Metabolic Effects of Antipsychotic Substitution in Children
- Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
- Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia
- Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
- Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use
- Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
- Risperidone Maintenance Treatment in Schizophrenia
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
- A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.
- Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Haloperidol vs Olanzapine for the Management of ICU Delirium
- Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions
- Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions
- Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
- Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia
- Pharmacological Treatment of Children and Adolescents With Severe Mood Dysregulation
- Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
- Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
- 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study
- A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia
- Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia
- Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
- A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
- Treatment of Severe Childhood Aggression (The TOSCA Study)
- As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations
- A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
- Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
- A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
- A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
- Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children
- Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia
- Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia
- Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
- Efficacy Study on Cognitive Functions in Schizophrenic Patients
- Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder
- Actigraphic Analysis of Treatment Response
- Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
- Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
- Anticholinergic Burden in Schizophrenia
- Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
- Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
- A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
- Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649
- A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia
- Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
- Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose
- Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
- Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
- A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
- A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia
- Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
- A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients
- A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
- Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
- Quetiapine Extended Release Depression Symptoms
- Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia
- Effects of Modafinil on Olanzapine Weight Gain
- Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder
- Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder
- The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients
- The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)
- Risperidone and Zotepine in the Treatment of Delirium
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
- A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
- A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia
- Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
- Dementia Antipsychotics And Antidepressants Discontinuation Study
- Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
- Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
- Pharmacogenomics in Autism Treatment
- A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
- First Episode Schizophrenia and Cannabis-Related Disorder Study
- Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
- A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
- Study Evaluating Vabicaserin in Subjects With Schizophrenia
- Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
- A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
- Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
- Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone
- Metabolic Profile and Anthropometric Changes in Schizophrenia
- An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
- Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
- Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
- Quality of Life (QOL) in Female Patient With Schizophrenia
- A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
- The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
- Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
- Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
- Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
- Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
- Metabolic Signatures and Biomarkers in Schizophrenia
- RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
- Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia
- Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
- Antipsychotic Discontinuation in Alzheimer's Disease
- Tamoxifen in Treatment of Acute Mania
- Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
- Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva
- An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
- A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
- Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder
- Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.
- A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
- Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
- Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint
- SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia
- Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
- A Definitive Estrogen Patch Study (ADEPT)
- The New Strategy for Pharmacological Treatment in People With Schizophrenia
- Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
- Switch Study of Existing Atypical Antipsychotics to Bifeprunox
- Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
- Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia
- Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
- Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
- Optimizing Response in Psychosis Study
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
- Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility
- Identification and Treatment of the Liability to Develop Schizophrenia
- Effect of Quetiapine on Negative Symptoms and Cognition
- Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients
- A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
- Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle
- Risperidone Augmentation for Treatment-Resistant Aggression in ADHD
- A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
- Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
- A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
- Risperidone Augmentation in Patients With Schizophrenia
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
- Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
- A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
- Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
- Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
- Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
- Risperidone LA Heathcare Resource Study
- CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
- An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia
- SPECT Study With SB-773812 In Schizophrenic Patients
- A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
- An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia
- A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
- Movement Disorders Caused by Antipsychotic Drugs in Older Patients
- A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children
- Treatment of Bipolar Mania in Older Adults
- Safety and Efficacy of Seroquel in First Episode Schizophrenia
- A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
- A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
- A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
- A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
- Trial of Aripiprazole in the Treatment of CD in Adolescents
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
- A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
- A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
- A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
- An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
- A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
- A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
- Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
- Side Effects of Newer Antipsychotics in Older Adults
- A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
- Schizophrenia Trial of Aripiprazole
- Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
- A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
- Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-ac
- A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
- A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
- Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia
- A Switch Study of BMS-337039 in Schizophrenic Out-patients
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia
- Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
- A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
- Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
- Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
- A Comparative Study of New Medications for Psychosis in Adolescents
- Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
- PREvent First Episode Relapse (PREFER)
- Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
- A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
- A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
- The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania
- A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
- A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- D-Serine Monotherapy for Schizophrenia
- Risperidone Augmentation for PTSD
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)
- A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
- A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
- Aripiprazole in Children With Autism: A Pilot Study
- Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma
- Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
- Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
- Risperidone vs. Paroxetine for Panic Attacks
- A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
- Janssen - Glucose Regulation/Risp/Olanz
- Metabolic Effects of Antipsychotics in Children
- Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
- Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
- Improving Work Outcome in People With Recent-onset Schizophrenia
- Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
- Use of Risperidone in ECT for Treatment Resistant Depression
- Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
- Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
- Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
- Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
- Clozapine IM and Aggression in Schizophrenic Patients
- Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
- Cognition, Functioning and Quality of Life
- Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
- Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
- Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
- Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
- Serotonin 1A Agonists and Cognition in Schizophrenia
- Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment
- Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
- Risperdal Consta for Bipolar Disorder
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
- Treatment of Major Depressive Disorder With Psychotic Features.
- Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant
- Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
- Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
- A Study of Risperidone Monotherapy in Bipolar Anxiety
- Risperidone and Suicidality in Major Depressive Disorder
- Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
- New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia
- Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
- Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
- One Year Drug Treatment in First-Episode Schizophrenia
- Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder
- Optimization of Acute Treatment in First Episode Schizophrenia
- Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
- The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
- Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
- A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
- Valnoctamide in Mania
- Treatment of Acute Schizophrenia With Vitamin Therapy
- Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
- Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial
- A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes
- Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
- Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
- Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease
- The Effects of Risperidone and Olanzapine on Thinking
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
- Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients
- Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia
- Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder
- Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients
- Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy
- A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
- Investigate Risperidone for the Treatment of Schizophrenia in Adolescents
- Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
- RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
- Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
- Treating Behavioral Disturbances in Individuals With Dementia
- Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia
- Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
- Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
- Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
- Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
- Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
- Schizophrenia Study In Adults
- Treatment and Outcome of Early Onset Bipolar Disorder
- A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
- Switching Medication to Treat Schizophrenia
- A Comparison of Seroquel vs. Risperidone in Schizophrenia
- CAFE Comparison of Atypicals in First Episode of Psychosis
- A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
- Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
- The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
- Antipsychotic Response in Schizophrenia
- Specific Interventions for Agitation in Alzheimer's Disease
- CATIE-Alzheimer's Disease Trial
- CATIE- Schizophrenia Trial
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
- Glucose Regulation During Risperidone and Olanzapine Treatment
- Treatment of Autism in Children and Adolescents
- Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
- Treatment for First-Episode Schizophrenia
- Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
- Risperidone for the Treatment of Cocaine Dependence - 7
- Infusion Laboratory: Protocol 3 (Risperidone) - 4
- Early Phase II Trials for Cocaine Medication Development - 1
- Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
- Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
- Early Phase II Trials for Cocaine Medication Development - 1
- Risperidone Treatment in Dually-Diagnosed Individuals - 2
Clinical trials list
click for details